Entering text into the input field will update the search result below

European advisory group backs Merck's HIV meds Delstrigo and Pifeltro

Sep. 20, 2018 4:37 PM ETMerck & Co., Inc. (MRK) StockBy: Douglas W. House, SA News Editor2 Comments
  • The European Medicines Agency's advisory group CHMP adopts a positive opinion backing approval for Merck's (NYSE:MRK) DELSTRIGO (doravirine, lamivudine and tenofovir disoproxil fumarate) and PIFELTRO (doravirine) for the treatment of adults with chronic HIV-1 infection.
  • A final decision by the European Commission usually takes ~60 days.

Recommended For You

About MRK Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
MRK--
Merck & Co., Inc.